Beta Bionics, Inc. <BBNX.O>: Truist Securities Raises Target Price to $23 From $22
BBNX•Related News
Astrana Health, Inc. <ASTH.O>: Oppenheimer initiates coverage with outperform rating; target price $53
ASTH•
From hallucinating AI chatbots to wiping out humanity: How did we get here?
QQQ•
Vishay Intertechnology Inc <VSH.N>: Oppenheimer initiates coverage with outperform rating; target price $42
VSH•
LNG demand in China, India and Pakistan expected to rebound after US-Iran war ends
XOM•
Solaris Energy Infrastructure, Inc. <SEI.N>: Needham Raises Target Price to $104 From $98
SEI•